HTG Molecular Diagnostics Net Tangible Assets

HTG Molecular Diagnostics (HTGMQ) currently reports a net tangible assets of $470K as of March 2023. That compares with $11M in the prior-year period — down 95.8% year over year. Use the charts on this page to explore HTG Molecular Diagnostics's net tangible assets history and peer comparisons.

HTG Molecular Diagnostics's net tangible assets decreased from $11M to $470K — a 95.8% year-over-year decrease (period ending March 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

HTG Molecular Diagnostics reported $470K in net tangible assets as of March 2023. That compares with $11M in the prior-year period — down 95.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $470K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for HTG Molecular Diagnostics, and consider following HTGMQ for alerts when major investors trade the stock.

HTG Molecular Diagnostics is classified in the Healthcare sector. On net tangible assets, it currently shows $470K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HTGMQ with unrelated industries.